Edmond Sabo
Papers
1
Total Citations
103
H-Index
1
About
Edmond Sabo is a distinguished pathologist and researcher whose work centers on improving the diagnostic accuracy of prostate cancer, with a particular focus on the interplay between prostate volume, PSA density, and clinically significant disease. His landmark 2020 study, "Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume," has garnered over 100 citations, underscoring its influence on urological oncology. In this work, Sabo demonstrated that PSA density—adjusted for prostate volume—is a far more reliable predictor of aggressive, clinically significant prostate cancer than PSA levels alone, helping to reduce unnecessary biopsies and overtreatment of indolent tumors. Beyond this, his research bridges histopathology and quantitative biomarkers, refining risk stratification for patients. Sabo’s contributions have shaped clinical guidelines and informed the development of more precise diagnostic protocols. His work is widely cited by clinicians and researchers seeking to optimize prostate cancer screening, making him a key figure in the shift toward personalized, risk-adapted approaches in uropathology.
Research Focus
Key Achievements
Top Papers
- 1